A further study demonstrated that CXCL8 induced tumor-associated neutrophil and granulocytic MDSC extrusion of NETs, which shield tumor cells from contact with CD8+ T cells and limit the anti-PD-1 immune response to cancer [98]. This evidence concerns the gene CD8A and neoplasm.